Page last updated: 2024-08-17

hydroxyproline and navitoclax

hydroxyproline has been researched along with navitoclax in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Chung, EJ; Citrin, DE; Hauer-Jensen, M; Huang, L; Li, D; Lin, S; Meng, A; Pan, J; Wang, Y; Xu, Y; Zhang, J; Zhou, D1

Other Studies

1 other study(ies) available for hydroxyproline and navitoclax

ArticleYear
Inhibition of Bcl-2/xl With ABT-263 Selectively Kills Senescent Type II Pneumocytes and Reverses Persistent Pulmonary Fibrosis Induced by Ionizing Radiation in Mice.
    International journal of radiation oncology, biology, physics, 2017, 10-01, Volume: 99, Issue:2

    Topics: Alveolar Epithelial Cells; Aniline Compounds; Animals; Antineoplastic Agents; bcl-2-Associated X Protein; beta-Galactosidase; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p16; Cytokines; Hydroxyproline; Inflammation Mediators; Lung; Male; Mice; Mice, Inbred C57BL; Polymerase Chain Reaction; Proto-Oncogene Proteins c-bcl-2; Radiation Pneumonitis; Radiation, Ionizing; RNA, Messenger; Sulfonamides

2017